BioMérieux S.A.
BIM
Rangering i aksjer
#1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Aksjekurs
$103.97
Markedsverdi
$12.24B
Endring (1 dag)
0.52%
Endring (1 år)
-18.59%
Land
FR
Handel BioMérieux S.A. (BIM)
Kategori
Healthcare
P/S-forhold for BioMérieux S.A. (BIM)
P/S-forhold per October 2026 TTM: 2.53
Ifølge BioMérieux S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 2.53. Ved slutten av 2023 hadde selskapet et P/S-forhold på 3.23.
P/S-historikk for BioMérieux S.A. fra 2005 til 2026
P/S-forhold ved hvert års slutt
| År | P/S-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 2.53 | -17.45% |
| 2024 | 3.06 | -5.24% |
| 2023 | 3.23 | 0.44% |
| 2022 | 3.22 | -26.45% |
| 2021 | 4.38 | 0.06% |
| 2020 | 4.37 | 24.59% |
| 2019 | 3.51 | 25.46% |
| 2018 | 2.80 | -26.81% |
| 2017 | 3.82 | 43.98% |
| 2016 | 2.65 | 20.26% |
| 2015 | 2.21 | 10.85% |
| 2014 | 1.99 | 4.99% |
| 2013 | 1.90 | 4.92% |
| 2012 | 1.81 | 18.41% |
| 2011 | 1.53 | -28.88% |
| 2010 | 2.15 | -18.52% |
| 2009 | 2.63 | 23.58% |
| 2008 | 2.13 | -27.38% |
| 2007 | 2.94 | 49.35% |
| 2006 | 1.97 | 11.04% |
| 2005 | 1.77 | 0.00% |
P/S-forhold for lignende selskaper eller konkurrenter
| Selskap | P/S-forhold | Forskjell i P/S-forhold | Land |
|---|---|---|---|
| 5.37 | 112.66% |
US
|
|
| 6.29 | 149.09% |
US
|
|
| 21.02 | 732.12% |
US
|
|
| - | - |
CN
|
|
| 6.67 | 163.90% |
US
|
